Teva is a global biopharmaceutical company that manufactures and distributes generic medicines, innovative medicines, and biosimilars across more than 50 markets. The company operates three business segments: generic pharmaceuticals (producing over 350 products across diverse dosage forms), innovative medicines concentrated in central nervous system disorders and respiratory indications, and biosimilars for autoimmune and oncology conditions. Teva also produces active pharmaceutical ingredients for internal and external use and operates Anda, a pharmaceutical distribution business serving retail pharmacies, hospital systems, and insurers. Revenue is generated from the sale of generic medicines (high-volume, lower-margin), innovative and branded medicines (higher-margin with patent protection), biosimilar products, distribution services, and active pharmaceutical ingredient sales, with earnings affected by patent expirations, regulatory pricing pressures, and competitive market dynamics.